Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Alector (United States)
InstitutionResearch output, impact & collaborations
Alector (United States) is a research organisation in San Francisco, US. OpenAlex records 179 works and 20,612 citations for it. 116 researchers list it as their most recent affiliation.
179
Works
20,612
Citations
116
Researchers
71.3
Avg h-index
How has Alector (United States)'s publication output changed over time?
ScholarIQpublication output · 1999–2020
Output grew200% over the shown period — from 1 works in 1999 to 3 in 2020.
1
1
1
2
2
2
3
1999200320052006201620182020
Who are the most-cited researchers behind Alector (United States)?
ScholarIQtop researchers by citations
What are the most-cited papers on Alector (United States)?
ScholarIQmost cited works
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
Alan Sandler, Robert J. Gray, Michael C. Perry, Julie R. Brahmer, Joan H. Schiller, Afshin Dowlati, Rogério Lilenbaum, David H. Johnson
New England Journal of Medicine. 20065,784 CitationsOPEN ACCESS
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
Achim Rittmeyer, Fabrice Barlési, Daniel Waterkamp, Keunchil Park, Fortunato Ciardiello, Joachim von Pawel, Shirish M. Gadgeel, Toyoaki Hida, Dariusz M. Kowalski, Manuel Cobo, Diego Cortinovis, Joseph W. Leach, Jonathan Polikoff, Carlos H. Barrios, Fairooz F. Kabbinavar, Osvaldo Arén Frontera, Filippo de Marinis, Hande Turna, Jong-Seok Lee, Marcus Ballinger, Marcin Kowanetz, Pei He, Daniel S. Chen, Alan Sandler, David R. Gandara
The Lancet. 20164,795 CitationsOPEN ACCESS
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
Mark A. Socinski, Robert M. Jotte, Federico Cappuzzo, Francesco Orlandi, Daniil Stroyakovskiy, Naoyuki Nogami, Delvys Rodríguez‐Abreu, Denis Moro‐Sibilot, Christian A. Thomas, Fabrice Barlési, Gene Grant Finley, Claudia Kelsch, Anthony Lee, Shelley Coleman, Yu Deng, Yijing Shen, Marcin Kowanetz, Ariel López-Chávez, Alan Sandler, Martin Reck
New England Journal of Medicine. 20183,781 CitationsOPEN ACCESS
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
Leora Horn, Aaron S. Mansfield, Aleksandra Szczęsna, Libor Havel, Maciej Krzakowski, Maximilian J. Hochmair, Florian Huemer, György Losonczy, Melissa L. Johnson, Makoto Nishio, Martin Reck, Tony Mok, Sivuonthanh Lam, David S. Shames, Juan Liu, Beiying Ding, Ariel López-Chávez, Fairooz F. Kabbinavar, Wei Lin, Alan Sandler, Stephen V. Liu
New England Journal of Medicine. 20183,565 CitationsOPEN ACCESS
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
Louis Fehrenbacher, Alexander I. Spira, Marcus Ballinger, Marcin Kowanetz, Johan Vansteenkiste, Julien Mazières, Keunchil Park, David C. Smith, Á. Artal, C. Lewanski, Fadi Braiteh, Daniel Waterkamp, Pei He, Wei Zou, Daniel S. Chen, Jing Yi, Alan Sandler, Achim Rittmeyer
The Lancet. 20162,812 Citations
How much of the research on Alector (United States) is open access?
ScholarIQopen access share
75%OPEN ACCESS
Gold
0%
Green
17%
Hybrid
8%
Bronze
50%
Closed
25%
Related on ScholarIQ
Amyotrophic Lateral Sclerosis Research
Top Topic
Neuroinflammation and Neurodegeneration Mechanisms
Top Topic
Alzheimer's disease research and treatments
Top Topic
Inflammation biomarkers and pathways
Top Topic
Dementia and Cognitive Impairment Research
Top Topic
Parkinson's Disease Mechanisms and Treatments
Top Topic